Eris Lifesciences Limited IPO

Eris Lifesciences Limited is listed in the MAINBOARD segment with a price band of ₹600 to ₹603. The figures below are as reported by the exchanges and public sources.

Eris Lifesciences Limited IPO — key facts

• The Eris Lifesciences Limited IPO price band is ₹600 to ₹603 per share.
• As of 5 September 2026, the Eris Lifesciences Limited IPO subscription status is 3.29x overall.
• The issue is open from 16-JUN-2017 to 20-JUN-2017.
• Eris Lifesciences Limited listed on 29-JUN-2017.
• Eris Lifesciences Limited listed at ₹601.05. The listing loss was 0.3% against the upper end of the issue price band.

Eris Lifesciences Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹600 – ₹603

Issue size

₹1740.49 Cr

Offer for sale

₹1740.49 Cr

Opens

16-JUN-2017

Closes

20-JUN-2017

Listing

29-JUN-2017

Total subscription

3.29x

Retail

3.51x

QIB

4.68x

NII

0.45x

Lead managers

Axis Capital (left lead)

Listing price

₹601.05

Listing day change

-0.3%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.